IMMUNOLOGY

Prof. Dr. Hansjörg Schild (r.) und Prof. Dr. Tobias Bopp leiten den Sonderforschungsbereich (SFB) 1292 "Gezielte Beeinflussung von konvergierenden Mechanismen ineffizienter Immunität bei Tumorerkrankungen und chronischen Infektionen" seit 2017. (Foto: Stefan F. Sämmer)IMMUNOLOGY

Tumors and chronic diseases outsmart the immune system

For decades, researchers at the University Medical Center of Johannes Gutenberg University Mainz (JGU) have been doing outstanding work in the field of immunology. In 2017, their work was further enhanced through the establishment of the Collaborative Research Center (SFB) 1292 on "Targeted influencing of the convergent mechanisms of ineffective immunity in cancer and chronic infections". The German Research Foundation (DFG) agreed to fund it to the tune of EUR 9.7 million for an initial period of four years.

more ... >